Inventor · disambiguated record
Gerardo Enrique Guillen Nieto
Also filed as: GUILLEN NIETO GERARDO E · GUILLEN NIETO GERARDO ENRIQUE · GUILLÉN NIETO GERARDO ENRIQUE
20 granted patents·15 pending applications·65 citations·filing 1998–2022
92Inventor score
Files withCT INGENIERIA GENETICA BIOTECNOLOGIA11CT INGENIERIA GENETICA BIOTECH8AGUILAR RUBIDO JULIO CESAR2ACOSTA JORGE BERLANGA1AGUILAR RUBIDO JULIO C1
Top patents by PatentIndex Score
35 records- 0181US7799760B2Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation preventionCT INGENIERIA GENETICA BIOTECH·Filed 2008·Granted Sep 21, 2010·8 cites·21 claims
- 0279US7279164B2Chimeric proteins that induce effects directed against virusesCT INGENIERIA GENETICA BIOTECH·Filed 2002·Granted Oct 9, 2007·11 cites·7 claims
- 0374US8431524B2Peptide antagonist of interleukin-15 activitySANTOS SAVIO ALICIA·Filed 2009·Granted Apr 30, 2013·6 cites·9 claims
- 0473US7465704B2Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF)CT DE INGENIERA GENETICA Y BIO·Filed 2002·Granted Dec 16, 2008·12 cites·19 claims
- 0572US7790173B2Pharmaceutical compound capable of induce immune protective response against Dengue virus having the capsid protein of the Dengue virusCT INGENIERIA GENETICA BIOTECH·Filed 2006·Granted Sep 7, 2010·4 cites·10 claims
- 0669US7361638B2Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defectCT INGENIERIA GENETICA BIOTECH·Filed 2001·Granted Apr 22, 2008·8 cites·7 claims
- 0764US11759517B2Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Granted Sep 19, 2023·0 cites·3 claims
- 0859US12070497B2Hepatitis B vaccine transnasal administration systemTOKO YAKUHIN KOGYO KK·Filed 2019·Granted Aug 27, 2024·0 cites·16 claims
- 0958US11564975B2Use of GHRP-6 as late cardioprotective and cardiac restoration medicamentCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2019·Granted Jan 31, 2023·0 cites·7 claims
- 1058US8999931B2Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogenJUNCO BARRANCO JESUS ARTURO·Filed 2009·Granted Apr 7, 2015·0 cites·9 claims
- 1156US2024317827A1Linear peptides inhibiting ck2-mediated phosphorylation and compositions comprising sameCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1253US11491218B2Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2017·Granted Nov 8, 2022·0 cites·4 claims
- 1352US9034826B2Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathyCT INGENIERIA GENETICA BIOTECH·Filed 2013·Granted May 19, 2015·0 cites·8 claims
- 1452US2024139105A1Pharmaceutical composition containing ghrp-6CT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1551US2006193853A1Combinations of growth-and hormone-regulating factors for the treatment of neoplasiaFUENTES EDDY B·Filed 2003·Application pending·0 cites
- 1650US2024350611A1Recombinant antigen for inducing an immune response against the zika virusCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2022·Application pending·0 cites
- 1748US8642552B2Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathyFERNANDEZ MONTEQUIN JOSE IGNACIO·Filed 2007·Granted Feb 4, 2014·0 cites·5 claims
- 1847US9364524B2Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogenCT INGENIERIA GENETICA BIOTECH·Filed 2015·Granted Jun 14, 2016·0 cites·4 claims
- 1947US2023190866A1Peptide for the treatment of cytokine storm syndromeCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2047US2023405106A1Chimeric protein comprising the receptor binding domain of the corona virus spike protein and compositions comprising themCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2146US2025282828A1Peptides for the treatment of respiratory infections of viral originCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2021·Application pending·0 cites
- 2246US2009104223A1Method for Obtaining Antigenic Aggregates and the Use Thereof in FormulationsAGUILAR RUBIDO JULIO CESAR·Filed 2007·Application pending·0 cites
- 2345US2021196793A1Pharmaceutical Combination Comprising Epidermal Growth Factor and Secretagogue Peptide GHRP6 for the Restoration of Brain DamageCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2019·Application pending·0 cites
- 2444US2014011216A1Engineered pertactin variants for vaccine useQUINTANA VAZQUEZ DIOGENES·Filed 2013·Application pending·0 cites
- 2543US2007166333A1Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulationsNIEBLA PEREZ OLIVIA·Filed 2004·Application pending·0 cites
- 2643US2007275012A1Pharmaceutical Compositions for Therapeutic UseAGUILAR RUBIDO JULIO C·Filed 2004·Application pending·0 cites
- 2737US9518085B2Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseasesPENTON ROL GISELLE·Filed 2012·Granted Dec 13, 2016·0 cites·7 claims
- 2836US6358933B1Formulation of nucleic acid and acemannanCT INGENIERIA GENETICA BIOTECH·Filed 1999·Granted Mar 19, 2002·7 cites·12 claims
- 2936US2009221512A1Pharmaceutical composition containing ghrp-6 to prevent and eliminate fibrosis and other pathological deposits in tissuesACOSTA JORGE BERLANGA·Filed 2007·Application pending·0 cites
- 3036US2012308615A1Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunizationAGUILAR RUBIDO JULIO CESAR·Filed 2010·Application pending·0 cites
- 3135US9463235B2Dengue virus vaccine compositionCENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA·Filed 2013·Granted Oct 11, 2016·0 cites·13 claims
- 3235US2017119733A1Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseasesCT INGENIERIA GENETICA BIOTECNOLOGIA·Filed 2016·Application pending·0 cites
- 3333US8110182B2Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyaninROL GISELLE PENTON·Filed 2006·Granted Feb 7, 2012·0 cites·6 claims
- 3430US7374766B1Compositions containing virus-like particles as immunopotentiators administered through the mucosaCT DE INGENIERIA GENETIC Y BIO·Filed 1999·Granted May 20, 2008·5 cites·4 claims
- 3530US6355414B1Immunopotentiating formulations for vaccinal useCT INGENIERIA GENETICA BIOTECH·Filed 1998·Granted Mar 12, 2002·4 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →